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Abstract
Background: The G subfamily of ABC (ATP-binding cassette) transporters of Leishmania include 6 genes (ABCG1-G6),
some with relevant biological functions associated with drug resistance and phospholipid transport. Several studies
have shown that Leishmania LABCG2 transporter plays a role in the exposure of phosphatidylserine (PS), in virulence
and in resistance to antimonials. However, the involvement of this transporter in other key biological processes has not
been studied.
Methods: To better understand the biological function of LABCG2 and its nearly identical tandem-repeated transporter
LABCG1, we have generated Leishmania major null mutant parasites for both genes (ΔLABCG1-2). NBD-PS uptake,
infectivity, metacyclogenesis, autophagy and thiols were measured.
Results: Leishmania major ΔLABCG1-2 parasites present a reduction in NBD-PS uptake, infectivity and virulence. In
addition, we have shown that ΔLABCG1-2 parasites in stationary phase growth underwent less metacyclogenesis and
presented differences in the plasma membrane’s lipophosphoglycan composition. Considering that autophagy is an
important process in terms of parasite virulence and cell differentiation, we have shown an autophagy defect in
ΔLABCG1-2 parasites, detected by monitoring expression of the autophagosome marker RFP-ATG8. This defect
correlates with increased levels of reactive oxygen species and higher non-protein thiol content in ΔLABCG1-2
parasites. HPLC analysis revealed that trypanothione and glutathione were the main molecules accumulated in
these ΔLABCG1-2 parasites. The decrease in non-protein thiol levels due to preincubation with buthionine sulphoximide
(a γ-glutamylcysteine synthetase inhibitor) restored the autophagy process in ΔLABCG1-2 parasites, indicating
a relationship between autophagy and thiol content.
Conclusions: LABCG1-2 transporters from Leishmania could be considered as phosphatidylserine and non-
protein thiol transporters. They probably accomplish transportation in conjunction with other molecules that
are involved in oxidative stress, autophagy, metacyclogenesis and infectivity processes. The overall conclusion
is that LABCG1-2 transporters could play a key role in Leishmania cell survival and infectivity.
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Background
Leishmaniasis is considered a neglected tropical disease
caused by protozoan parasites of the genus Leishmania
[1]. It is prevalent in 98 countries around the world and
the current incidence is estimated about 0.2–0.4 million
cases of visceral leishmaniasis and 0.7–1.2 million cases
of the cutaneous form [1].
ABC (ATP-binding cassette) transporters are consti-
tuted by two homologous halves to be functional. The
binding of substrates occurs in the transmembrane do-
main while the hydrolysis of ATP needed for the transport
occurs in a cytosolic nucleotide binding domain [2]. The
Leishmania genome contains 42 ABC genes classified in 9
subfamilies (from ABCA to ABCI) [3, 4]. The ABCG sub-
family includes half-transporters that require homo/het-
erodimerisation to become functional [5]. LABCG2 has
two additional imperfect tandem repeats in chromosome
6 of Leishmania (LABCG1 and LABCG3) [6]. LABCG1
and LABCG2 are almost identical (93% amino acid iden-
tity); however, the LABCG3 protein is truncated at the nu-
cleotide binding and transmembrane domains. Expression
of a dominant-negative version of the half-transporter
LABCG2 produces a defect in the external surface expos-
ure of endogenous phosphatidylserine (PS), which is nor-
mally asymmetrically confined on the inner leaflet of
eukaryotic cells’ plasma membranes. Additionally, these
parasites present a decrease in the infection of mouse
peritoneal macrophages and reduced virulence in a mouse
model of cutaneous leishmaniasis [6].
The process by which trypanosomatids metabolically
differentiate from procyclic promastigotes (non-infect-
ive) into metacyclic promastigotes (infective) is the
metacyclogenesis [7]. In Leishmania species, the place
where metacyclogenesis occurs is in the insect vector; in
vitro, this process can be induced by acidification of the
medium after the growth of parasites from logarithmic
to stationary phase [8]. Stage-specific variations are ob-
served throughout the parasite life-cycle, such as the
considerable structural modifications to lipophosphogly-
can (LPG) composition and structure during parasite
metacyclogenesis. LPG plays an important role in estab-
lishing Leishmania infection by conferring resistance to
lysis mediated by complement and protecting from oxi-
dative injury, by facilitating the binding to other recep-
tors of macrophages and by remodeling the initial
phagolysosome [9–11]. To date, there are no reports of
a Leishmania ABC transporter involved in metacyclo-
genesis or modification of LPG composition.
In Leishmania, autophagy is a well-conserved process
required for degradation of proteins and organelles during
cellular differentiation and metacyclogenesis [12]; the
ATG8-lipidation pathway plays an important role for
autophagosome synthesis during autophagy. Moreover,
the relationships between oxidative stress, caused by high
levels of reactive oxygen species (ROS), and autophagy in
Leishmania have been clearly established. Also, glutathi-
one (GSH) is known to be involved in mitochondrial
autophagy regulation in yeast [13]. Evidence that thiol
pools have a modulatory function in autophagy progres-
sion due to an ABCC1-dependent extrusion has also been
published [14]. The intracellular redox state of thiol pools,
which markedly depends on GSH levels, could drive
autophagy processes in carcinoma cells [14].
Recent studies indicate that human ABCG2 is involved
in autophagy regulation and strongly suggest that ABCG2
plays a key role in cell survival [15]. Tumour cells overex-
pressing ABCG2 enhance both autophagy and cell sur-
vival suggesting that this transporter assumes a previously
unknown role beyond its conventional drug-efflux func-
tion, probably associated with the transport of a specific
cellular substance (or substances) involved in autophagy
regulation [15].
On the other hand, some ABC transporters are able to
transport thiols while conjugated with other substances.
In this manner, several members of the ABCC subfamily
(MRP1, MRP2, MRP3, MRP4, MRP5 and CFTR) and
ABCB7/ATM1 have been described as GSH transporters
involved in cellular detoxification in mammalian cells
[16, 17]. Indeed, overexpression of ABCG2 in mamma-
lian cells altered intracellular GSH levels [18], although
the role this transporter plays in that modulation process
is still unclear. In Leishmania, LABCG2 overexpression
is involved in antimony resistance; this is mediated by a
lower accumulation due to intracellular sequestration
and increased antimony and thiol efflux through the par-
asites’ flagellar pocket [19].
In order to better understand the role of LABCG1-2
transporters in Leishmania cell survival and infectivity, we
have obtained null mutant parasites for both genes. Here,
we report that LABCG1 and 2 not only influence infectiv-
ity, virulence and metacyclogenesis but they also regulate
the rate of autophagy and redox metabolism. Taken as a
whole, the data presented here suggest that Leishmania
LABCG1-2 transporters have a previously unknown bio-
logical role associated with autophagy, establishing a rela-
tionship between thiol pool levels and autophagy.
Methods
Animals
BALB/c mice (six-week-old, female) from Charles River
Breeding Laboratories were maintained and fed under
pathogen-free conditions in the Animal Facility Service of
the Instituto de Parasitología y Biomedicina “López-Neyra”.
Strain and culture conditions
Leishmania major (MHOM/JL/80/Friedlin) was the
chosen strain. This line and derivative lines used in this
study were maintained in RPMI 1640 medium (Invitrogen,
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Paisley, UK) supplemented with 20% heat-inactivated fetal
bovine serum (hiFBS, Invitrogen) at 28 °C.
Generation of L. major LABCG1 and LABCG2 null mutants
To achieve targeted gene replacement of the L. major
LABCG1 and LABCG2 genes (GeneDB-L. major, acces-
sion codes LmjF06.0080 and LmjF06.0090, respectively),
we constructed a targeting DNA fragment in which the
hyg gene, which confers resistance to hygromycin B, was
flanked at the 5′ end by a 1.5-kb region containing the
LABCG2 stop codon and at the 3′ end by a 1.5-kb re-
gion containing the LABCG1 initiation codon. The dif-
ferent fragments were amplified by PCR from genomic
DNA using the following pairs of complementary primers:
P1 forward (5′-atg cgg ccg ccg cTG TTT ATC TGT GTT
ATC G-3′) and P2 reverse (5′-atg gat cct cta gaa ttt aaa
tGT AGA CAG GCG GAG AAG GCA G-3′) for the 5′
region; P3 forward (5′-att cta gaG TTG TAA GCT GCT
GTG CGG CGT AAC-3′) and P4 reverse (5′-atg gat ccG
CAC ACG CGC GTA GGA AAG CAG-3′) for the 3′ re-
gion; or from the cLHYG vector: P5 (5′-GTA GAT CTA
CCA CTT TCT GCC TTC TG-3′) and P6 (5-GGA AGC
TTC TAT TCC TTT GCC CTC GGA CG-3′) for the re-
sistance cassettes. All fragments were subcloned into the
pGEM®-T vector (Promega, Madrid, Spain).
Leishmania major promastigotes in logarithmic phase
of growth were transfected with 2 μg of linearized DNA
targeting constructions by electroporation Nucleofector™
(Lonza, Köln, Germany). In the first round of selection,
the electroporated promastigotes were incubated in
drug-free culture medium for 24 h, and plated in 96-well
microplates in the presence of 10 μg/ml hygromycin B.
By this method, several single knock-out clones were ob-
tained. In a second round of gene targeting, loss of het-
erozygosity was promoted by increasing the hygromycin
B concentration up to 500 μg/ml and plating into agar
plates as previously described [20]. The clones obtained
were analysed by Southern blot.
Southern blot analysis
Genomic DNA was purified from WT (wild-type) and
LABCG1-2 null mutant (ΔLABCG1-2) parasites and
then digested with AgeI. Digested DNA was then sepa-
rated using agarose gel electrophoresis, transferred on to
a nylon membrane and hybridised to digoxigenin-
labelled (DIG) DNA probes from an intergenic region
between LABCG1 and LABCG2 (probe 1) or the 5′-
UTR of LABCG2 (probe 2), as described by [21]. Tem-
plates for synthesis of both probes were obtained by
PCR from genomic DNA of L. major using the pairs of
primers S1 forward (5′-ATC CAC CCG TCG ACA CAT
GC-3′) and S2 reverse (5′-CGC TGT CCT TCC GTT
TGT GG-3′), and S3 forward (5′-TGT TTA TCT GTG
TTA TCG-3′) and S4 reverse (5′-GTA GAC AGG CGG
AGA AGG CAG-3′), respectively. All procedures for the
DIG application system (Roche, Indianapolis, USA) were
carried out according to the manufacturer’s instructions.
Transfection of Leishmania lines
ΔLABCG1-2 parasites were transfected and selected for
resistance to 50 μg/ml of G418, when restituting LABCG2
(ΔLABCG1-2 + LABCG2), or to nourseothricin, in the
case of LABCG1 (ΔLABCG1-2 + LABCG1), as previously
described [6]. Double transfection techniques with the
plasmids previously used for single gene reconstitution
were performed to generate the add-back line ΔLABCG1-
2 + LABCG1-2. To monitor autophagy, parasites were
transfected with the plasmid pNUS RFP-ATG8 and se-
lected at a concentration of 50 μg/ml of blasticidin.
Analysis of fluorescent PS uptake in Leishmania lines
Accumulation of the fluorescent lipid analogue of PS
(NBD-PS, palmitoyl-2-[6-(7-nitrobenz-2-oxa-1,3-diazol-4-
yl) amino] hexanoyl-sn-glycero-3-phosphoserine, from
Avanti Polar Lipids (Birmingham, AL, USA) was deter-
mined by flow cytometry, as described previously [6].
Briefly, stationary-phase promastigotes (107/ml) were in-
cubated in HPMI buffer (20 mM HEPES, 132 mM NaCl,
3.5 mM KCl, 0.5 mM MgCl2, 5 mM glucose, 1 mM CaCl2,
pH 7.4) supplemented with 0.3% (w/v) BSA (Bovine serum
albumin) for 30 min at 28 °C and then labelled with
30 μM NBD-PS for 30 min at 28 °C. HPMI was supple-
mented with either 500 μM PMSF (phenylmethylsulfonyl
fluoride), or 5 mM DFP (diisopropylfluorophosphate) to
block the catabolism of NBD-lipids. NBD-PS remaining
on the cell surface was extracted twice by washing with
0.3% (w/v) BSA in PBS buffer. Parasites were resuspended
in PBS for flow cytometry analysis performed with a Beck-
ton Dickinson FACScan (San José, USA) equipped with an
argon laser operating at 488 nm.
In vitro infection of mouse peritoneal macrophages
The infection assays of peritoneal macrophages from
BALB/c mice (Charles River Ltd., Barcelona, Spain) were
performed as described previously [4] with some modifi-
cations. Briefly, the adherent macrophages placed in 24-
wells plate with coverslips, were infected for 4 h at 35 °C
with stationary-phase promastigotes at a parasite-to-cell
ratio of 2:1. The infection was stopped by washing with
serum free medium and the infected macrophages were
incubated for 24, 72 and 120 h. After incubation, the
cultures were processed and stained with DAPI (4′,6-
diamidino-2-phenylindole dilactate) for the calculation
of the percentage of infection and the mean number of
amastigotes by fluorescence microscopy.
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Analysis of in vivo infection
Animals (6 mice/group) were injected subcutaneously in
their left hind footpads with 105 stationary-phase L. major
promastigotes resuspended in PBS. Progression of the dis-
ease was monitored with weekly measurements of the
footpad swelling, assessed by measuring the width of in-
fected footpad, and extent of the cutaneous lesion on the
infected footpad using a digital calliper (Mitutoyo, Japan),
as described previously [22].
Lectin-mediated agglutination of Leishmania lines
Promastigotes were agglutinated using lectin PNA (Peanut
agglutinin) in order to purify metacyclic promastigotes, as
described previously [23]. Parasites (1 × 108) were col-
lected in stationary-phase growth, washed twice with PBS
and incubated with 100 μg/ml of PNA for 10 min at room
temperature. The parasites were then centrifuged for
10 min at 500× g. Finally, non-agglutinated parasites
remaining in the supernatant were centrifuged, resus-
pended in PBS and counted with a haemocytometer to de-
termine the total cell number.
Western blot analysis
Parasites expressing RFP-ATG8 (autophagosomal marker)
were harvested at 1,000× g for 10 min and washed twice
in PBS; the pellets were either used immediately or stored
at -20 °C. The parasite lysates were obtained by resus-
pending parasite pellets in lysis buffer, containing 150 mM
Tris-HCl, 50 mM NaCl, 2% DDM (n-dodecyl-β-D-malto-
pyranoside) and a mixture of peptidase inhibitors
(Thermo Scientific, Rockford, USA).
Promastigote cell extracts were separated by SDS-
PAGE (10%) in the presence of 6 M urea and analysed
by Western blotting using an anti-RFP antibody (1:5,000;
Invitrogen) as described [12]. An enhanced chemilumin-
escence reaction with an ECL kit (Amersham, Rockford,
USA) was used for detection.
For LPG analysis, stationary-phase promastigotes
(8 days of their growth cycle) were harvested at 1,000× g
for 10 min and washed twice in PBS. Parasite lysates
used for this analysis were obtained as described above.
Promastigote cell extracts were separated by SDS-PAGE
(12%) and further analysed by Western blotting with the
monoclonal antibodies: WIC 73.9 (1:250), specific for
terminal Gal (β1-3) side-chains of LPG in plasma mem-
brane [24]; and with 3 F12 (1:500), which recognises spe-
cific arabinose residues of metacyclic forms [25].
For evaluation of metacyclogenesis, the metacyclic
specific protein HASPB was analysed using rabbit anti-
HASPB antibody at a 1:5,000 dilution [26]. The protein
3-hydroxy-3-methyl-glutaryl Coenzyme A synthase
(LmHMGS), used as an internal loading control, was
recognised using rabbit anti-LmHMGS antibody at a
1:100,000 dilution [27].
Measurement of ROS levels in Leishmania lines
The levels of intracellular ROS were measured as de-
scribed [12]. Briefly, promastigotes (1 × 107) were collected
at early logarithmic (EL), mid logarithmic (ML), early sta-
tionary (ES) and stationary (S) phases of growth. Cells
(2 × 106) were incubated with 0.1 mM H2DCF-DA for 2 h
at 28 °C. Fluorescence was then measured through flow
cytometry (excitation 380–420 nm, barrier filter 520 nm)
using a FACSCalibur™ (Becton-Dickinson, San Jose, USA).
Complement-mediated lysis in Leishmania lines
The susceptibility of promastigotes to complement-
mediated lysis was assessed following the protocol previ-
ously described [28] but with some modifications. Briefly,
promastigotes (1 × 107/ml) in a logarithmic or stationary
phase of growth were exposed to increasing concentra-
tions of fresh human serum for 30 min at 37 °C. After ex-
posure, resazurin was added and incubated at 28 °C for
24 h in order to discover the cell viability. Sample fluores-
cence (excitation: 540 nm; emission: 580 nm) was mea-
sured in an Infinite F200 Luminescence System (Tecan
Austria GmbH, Grödig, Austria).
Monitoring autophagy in Leishmania lines
Promastigotes expressing the autophagosomal marker
RFP-ATG8 were examined daily under a fluorescence
microscope in order to assess the proportion of parasites
containing autophagosomes and the number of these
structures per parasite. Three series of 200 parasites were
counted for each time-point in each experiment. To deter-
mine the relationship between thiol levels and autophagy
in Leishmania lines, 3 mM BSO (buthionine-[S,R]-sulfoxi-
mine, a γ-glutamylcysteine synthetase inhibitor) was
added for 48 h before the autophagy experiments.
Determination of intracellular non-protein thiol levels
To determine intracellular thiol levels, we used the fluo-
rimetric probe CellTracker™ as described previously [19].
Log phase parasites (107/ml) were grown in M-199
medium plus 10% hiFBS. They were then washed with
PBS and incubated with 2 μM CellTracker™ for 15 min
at 37 °C. After incubation, parasites were washed with
PBS again and analysed by flow cytometry using a
FACScan flow cytometer (Becton-Dickinson). Fluores-
cence emission between 515 and 545 nm was quantified
using CellQuest™ software.
To determine non-protein thiol levels, mid-log phase
promastigotes (1 × 109 cells) were collected by centrifuga-
tion (1,000× g, 10 min) and washed three times with PBS.
Proteins were precipitated with 2% trichloroacetic acid for
30 min and the supernatants obtained were neutralised
with Tris-HCl 1 M at pH 8. We used 1 mM of DTNB (5,5-
dithiobis-2-nitrobenzoic acid) for 10 min to measure the re-
duced non-protein thiol levels. The absorbance obtained at
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412 nm was interpolated on a GSH standard curve gener-
ated using different concentrations of reduced GSH.
To quantify and discriminate between the different thiol
molecules in the sample, the cell pellet was lyophilised and
resuspended in 100 μl of HEPES (40 mM, pH 8.0) contain-
ing a freshly prepared aqueous solution of NaBH4 (sodium
borohydride, 100 mM final concentration). Samples were
allowed to set for 30 min at room temperature and thiols
were then derivatized with monobromobimane (mBBr,
2 mM final concentration) for 5 min at 70 °C for detection.
Following derivatisation, proteins were precipitated and
any excess NaBH4 removed by acid incubation with
methanesulphonic acid (4 M, 100 μl) for 2 h on ice.
Acid soluble thiols were separated by reverse phase
ion-pairing HPLC on an Agilent C18 column and ana-
lysed through fluorometric detection [29]. Quantitation
and validation were accomplished using T [SH] 2 and
GSH standards.
Statistical analysis
Statistical treatment of data obtained between groups
were performed using the Student’s t-test. Differences
were considered significant at a level of P < 0.05.
Results and discussion
Molecular characterisation of L. major LABCG1 and
LABCG2 null mutants
Genes encoding LABCG1 and LABCG2 are tandemly
linked with each other on chromosome 6 of Leishmania
(LABCG1-2) (Fig. 1a) [6]. A L. major mutant lacking
both LABCG1 and LABCG2 genes (ΔLABCG1-2) was
generated so we could further investigate the biological
function of these proteins. The chromosomal loci con-
taining the genes encoding LABCG1-2 were substituted
with antibiotic cassettes that confer resistance to hygro-
mycin B after applying a high selection pressure (up to
500 μg/ml) with hygromycin B on the parasite popula-
tion (Fig. 1a). In order to verify that both LABCG1-2
alleles were deleted, a Southern blot analysis was carried
out on genomic DNA using different probes: the inter-
genic region of LABCG1-2 (probe 1, Fig. 1a, b1), and
the 5′ UTR LABCG2 (probe 2, Fig. 1a, b2).
Loss of LABCG1-2 results in an increase in NBD-PS uptake
in Leishmania lines
After confirming the null mutant genotypes, ΔLABCG1-
2 parasites were tested for their capacity to transport
NBD-PS. As previously described, the expression of a
Fig. 1 Generation of L. major ΔLABCG1-2 parasites and accumulation of NBD-PS. a Restriction map of the native LABCG1-2 locus. Hybridisation
probes are shown by arrowheads and codon regions by black boxes. Black arrows indicate the direction of the transcription. Single allele LABCG1-2
mutant parasites were generated using hygromycin replacement construct and the remaining single allele was replaced by homologous recombination.
b Southern blot analysis of wild-type (WT) and ΔLABCG1-2 lines. DNA was digested with AgeI and subjected to Southern blot analysis using radiolabelled
probes that recognise the intergenic region of LABCG1 and LABCG2 (probe 1, b1) and the 5′ UTR region of LABCG2 (probe 2, b2). The positions of
molecular markers (Kbp) are indicated on the right. c Promastigotes of L. major lines: control (WT), ΔLABCG1-2, and add-back parasites
with LABCG1, LABCG2 and LABCG1-2 (ΔLABCG1-2 + LABCG1, ΔLABCG1-2 + LABCG2 and ΔLABCG1-2 + LABCG1-2) were incubated with NBD-PS for
30 min at 28 °C. After extraction with BSA and washing with PBS, the intracellular fluorescence was determined by flow cytometry. Data are the mean
± SD of three independent experiments. Statistical differences relative to the control values were calculated using Student’s t-test (*P < 0.05)
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dominant-negative mutant version of LABCG2 results in
a significantly higher accumulation of NBD-PS [6]. As
expected, ΔLABCG1-2 parasites showed a higher accu-
mulation of NBD-PS compared to WT and add-back
parasites (t-test: t(4) = 12.92, P = 0.0002 for WT; t-test:
t(4) = 13.06, P = 0.0002 for ΔLABCG1-2 + LABCG1-2;
Fig. 1c). Additionally, parasites ΔLABCG1-2 + LABCG1,
ΔLABCG1-2 + LABCG2 and ΔLABCG1-2 + LABCG1-2
have similar NBD-PS accumulation values (Fig. 1c), sup-
porting the suggestion that the function of LABCG1 and
LABCG2 transporters is similar to the one previously
considered when taking into account their high % of
amino acid identity (93%). Thus, our results support that
Leishmania LABCG1 and LABCG2 transporters have PS
floppase activity. We decided to continue the functional
studies using add-back parasites ΔLABCG1-2 + LABCG1-
2 to achieve the highest possible level of similarity with
the WT line, avoiding potential functional differences
between LABCG1 and LABCG2 transporters.
Decreased infectivity and virulence in ΔLABCG1-2
parasites
To determine the biological effects of the genetic defi-
ciencies in LABCG1-2 transporters on Leishmania, the
infectivity and survival of WT, ΔLABCG1-2 or add-back
parasites in mouse peritoneal macrophages were deter-
mined at 24, 72 and 120 h post-infection. The results
show that ΔLABCG1-2 parasites have a lower percent-
age of infection (20–35%) compared with WT and add-
back lines (65–75%) (t-test: t(4) = 9.14–21.02, P = 0.0001–
0.0008; Fig. 2a). Additionally, the mean number of para-
sites per infected macrophage in ΔLABCG1-2 parasites
was significantly lower compared to the other lines, indi-
cating a significantly lower parasite entry into macro-
phages at 24 h post-infection; these parasites were viable
and replicate inside the macrophages at 72 and 120 h
(t-test: t(4) = 4.35–36.87, P = 0.0001–0.0121; Fig. 2b).
We then analysed whether these results were linked to
a lower in vivo virulence of the parasites using a mouse
model of cutaneous leishmaniasis. Mice infected with
WT and add-back parasites showed progressive swelling
and lesions after 5 weeks (Fig. 3a-c), whereas mice
infected with ΔLABCG1-2 parasites presented minimal
lesion pathology and significantly lower footpad swelling
(Fig. 3a-c). Thus, we confirmed that LABCG1-2 are rele-
vant transporters involved in infectivity and are essential
for disease development.
Defect in metacyclogenesis and changes in LPG
composition in ΔLABCG1-2 parasites
Based on the above results, we assessed whether metacyclo-
genesis was impaired in ΔLABCG1-2 parasites by studying
several properties that distinguish metacyclic promastigotes
from procyclic ones; among others, agglutination to PNA,
susceptibility to human serum and expression of stage-
specific protein HASPB. ΔLABCG1-2 parasites displayed a
growth phenotype similar to the WT and add-back para-
sites in the usual culture medium (data not shown). Meta-
cyclic parasites were purified on day five of the growth
curve (stationary phase) by binding to the lectin PNA [30].
We observed that the percentage of non-agglutinated para-
sites (PNA−) was significantly lower in ΔLABCG1-2 para-
sites (1.3%) compared with WT (17%) (t-test: t(4) = 37.35, P
< 0.0001) and add-back parasites (16%) (t-test: t(4) = 20.78,
P < 0.0001; Fig. 4a). This phenotype was not observed in
the L. major line expressing a mutant version of LABCG2,
probably because the wild-type version of LABCG2 in these
parasites was not completely inactivated whereas the
LABCG2 expression in ΔLABCG1-2 parasites was entirely
suppressed.
Additionally, we analysed the susceptibility of the dif-
ferent Leishmania lines to lysis by human serum. As
shown in Fig. 4b1, the different Leishmania lines in the
logarithmic phase of growth presented a similar suscep-
tibility to lysis by human serum; however, in the station-
ary growth phase, ΔLABCG1-2 parasites showed an
increase in susceptibility to complement-mediated lysis
at 10% human serum of around 2.5-fold relative to the
controls (Fig. 4b2). Serum concentrations higher than
Fig. 2 Infectivity and survival of Leishmania lines in mouse peritoneal
macrophages. Mouse peritoneal macrophages were infected with
different L. major lines for 4 h at 35 °C. At 24 (black histograms),
72 (grey histograms) and 120 h (white histograms) post-infection, the
infectivity % (a) and the mean number of amastigotes/macrophages
(b) were determined. Data are the mean ± SD of three independent
experiments. Significant differences versus the respective control line
were determined using the Student’s t-test (*P < 0.05)
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10% were needed for a complete lysis of ΔLABCG1-2
parasites (Fig. 4b2); in contrast, only 50% of WT and
add-back metacyclic parasites were lysed at the same
serum concentration.
The only criterion supporting that ΔLABCG1-2 para-
sites had displayed metacyclogenesis was a similar ex-
pression of metacyclic specific protein HASPB in the
different stationary-phase promastigotes (Fig. 4c). A
similar situation has been described in a L. major
mutant VPS4 line involved in endosome sorting and
autophagy [28]. In this case, the mutant parasites failed
to differentiate into metacyclic forms as determined by
the absence of HASPB and SHERP metacyclic specific
proteins and a higher susceptibility to lysis by human
serum [28]. However, the study did not observe any
changes in the percentage of PNA− parasites. Our results
concerning the unmodified expression of the HASPB
protein in ΔLABCG1-2 parasites established markers
(although they lacked others) for metacyclic promasti-
gotes indicating that the presence of the specific meta-
cyclic protein HASPB was not enough to confer an
infective phenotype. Probably, as suggested for the L.
major mutant VPS4 line, the biosynthetic pathway of
LPG assembly is induced independently of metacyclic
specific proteins such as HASPB.
Thus, the reduced number of purified metacyclics,
the higher susceptibility to complement-mediated
lysis and the significant decrease in the infectivity of
ΔLABCG1-2 parasites could be due to the influence
of LABCG1-2 transporters in the appropriate expres-
sion of surface molecules (e.g. LPG) [31]. As previ-
ously shown, the complement resistance of L. major
promastigotes strongly depends on LPG chain length
and the formation of a thick protective glycocalyx
surface [9].
In all Leishmania species, LPG is composed by an GPI
anchor of a 1-O-alkyl-2-lysophosphatidylinositol lipid and
a heptasaccharide core, to which is attached a long phos-
phoglycan (PG) polymer composed of 15–30 [Galβ1,4-
Manα1-PO4] repeat units, playing a relevant role in
parasite survival [9]. Some evidence suggests that LPG
could decrease phagosome fusion properties at the first
stages of infection in macrophages [32]. In this way, an at-
tenuation of the virulence in promastigotes that lack LPG
has previously been described using a L. major lpg1−
mutant; and modifications in the LPG structures modu-
lated phagosome-endosome fusion.
Using two different monoclonal antibodies against
Leishmania LPG: (i) WIC79.3 (specific for terminal Gal
(β1-3) side-chains), and (ii) 3 F12 (specific for terminal
arabinose in side chains of metacyclic promastigotes),
we have observed differences in LPG composition in
ΔLABCG1-2 parasites since none of the antibodies
employed recognised its LPG during the stationary
growth phase compared with the WT and add-back
lines (Fig. 4d). In previous experiments, we have shown
that ΔLABCG1-2 parasites were agglutinated with
PNA, hence discarding the possibility of a lack of LPG.
We hypothesise that LABCG1-2 could be involved in
the intravesicular transport of oligosaccharides and the
loss of LABCG1-2 could affect the LPG composition
and the associated phenotypes. Future studies will aim
to identify the type of oligosaccharide transported by
LABCG1-2.
Fig. 3 ΔLABCG1-2 parasites are less infective in a mouse model of
cutaneous leishmaniasis. Susceptible BALB/c mice were infected with 105
WT (diamonds, black histograms), ΔLABCG1-2 (squares, grey histograms)
and add-back (ΔLABCG1-2 + LABCG1-2; triangles, white histograms) L.
major parasites in the stationary growth phase. Disease development
was monitored weekly by measuring the footpad swelling (a) and lesion
size (b). The pictures in c show the lesion at week 5 post-infection. The
results represent the mean ± SD of two independent experiments, with
6 mice per group. Mice were euthanized when the lesion size in controls
reached a value of 60–80 mm2. *P< 0.05 vs WT parasites
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ΔLABCG1-2 parasites are defective in autophagy
Autophagy has been considered as a survival stress re-
sponse to starvation conditions [28, 33]. Considering that
ΔLABCG1-2 parasites had altered the metacyclogenesis,
we decided to determine whether these parasites would
modify the autophagy as an important process for protein
and organelle degradation during cellular differentiation
and metacyclogenesis. Leishmania major ATG8 has been
identified as an useful marker for observing autophago-
somes in Leishmania [28]. Thus, to follow the formation
of autophagosomes, we expressed ATG8 fused with RFP
at its N-terminus in WT, ΔLABCG1-2 and add-back para-
sites. Afterwards, the formation of autophagosomes was
analyzed through the 10-day growth cycle of Leishmania
lines (Fig. 5a). RFP-ATG8 was distributed throughout the
cytoplasm in logarithmic-phase promastigotes; however,
during the early stationary-phase, autophagosomes could
be identified in some of the parasites as punctate struc-
tures in the cytoplasm [28]. The results show that the
number of parasites containing autophagosomes increased
from early log to early stationary-phase in WT and add-
back promastigotes, with a maximum at day 8 (Fig. 5a).
However, in ΔLABCG1-2 parasites, the percentage of cells
with autophagosomes was significantly lower at the differ-
ent time-points (t-test: t(4) = 8.10–24.74, P = 0.0001–
0.0013; Fig. 5a). When parasites progressed to stationary
phase and differentiate into metacyclic forms, the percent-
age of cells with autophagosomes rapidly decreased at
days 9–10 (Fig. 5a). These results were validated by a well
established Western blot assay using anti-RFP antibody
on cell extracts fromWT, ΔLABCG1-2 and add-back lines
expressing RFP-ATG8, in order to ascertain the propor-
tion of cytosolic and lipid-associated forms of ATG8-PE
(Fig. 5b) [12, 28]. The lipidated bands (RFP-ATG8-PE) as-
sociated with the autophagosomal membrane migrate fas-
ter than the unlipidated bands (RFP-ATG8). In WT and
add-back lines at a stationary phase of growth, the propor-
tion of RFP-ATG8-PE increased significantly versus the
Fig. 4 Metacyclogenesis and Western blot analysis of LPG from different L. major lines. Proportion of metacyclic promastigotes of different L.
major lines including: control (WT, black histograms, diamonds), ΔLABCG1-2 (grey histograms, squares) and add-back parasites (ΔLABCG1-2 +
LABCG1-2, white histograms, triangles), in stationary phase of culture (day 5), assessed using the PNA assay (a). b Promastigotes (1 × 107/ml) in
the logarithmic (b1) or stationary phase (b2) of the growth curve were exposed to increasing concentrations of fresh human serum for 30 min at
37 °C. Resazurin was then added and the promastigotes incubated at 28 °C for 24 h in order to determine cell viability. Data are the mean ± SD
of three independent experiments. Significant differences versus the respective control line were determined using the Student’s t-test (*P < 0.05).
c Promastigotes (1 × 107) of WT, ΔLABCG1-2 and ΔLABCG1-2 + LABCG1-2 were lysed and collected in the stationary growth phase and Western
blot analysis with the antibodies HASPB and HMGS was performed. A Western blot assay representative of at least three independent experiments
is shown. The positions of molecular markers (kDa) are indicated on the left. d Promastigotes (1 × 107) of WT, ΔLABCG1-2 and ΔLABCG1-2 +
LABCG1-2 were collected at stationary phase of growth (8 days) and lysed as described in Materials and Methods. Western blot analysis of total
proteins from parasites incubated with the antibodies WIC79.3 (d1) or 3 F12 (d2) were performed at 1:250 and 1:500 dilutions, respectively. A
Western blot assay representative of at least three independent experiments is shown. The positions of molecular markers (kDa) are indicated on the left
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unlipidated form (Fig. 5b). In contrast, ΔLABCG1-2 para-
sites had a higher proportion of non-lipidated ATG8 ver-
sus WT and add-back lines (Fig. 5b), which is consistent
with a decrease in autophagosome biogenesis. These data
clearly suggest that ΔLABCG1-2 parasites have an au-
tophagy defect in which autophagosome formation is
inhibited, increasing the susceptibility to nutrient starva-
tion and consequently impairing the metacyclogenesis.
A defect in autophagy progress has been described in L.
major VPS4 and ATG4.2 mutant lines involved in endo-
some sorting and autophagy [28]; the authors concluded
that differentiation to metacyclic forms in Leishmania is
dependent on endosome function and autophagy.
Increased ROS levels in LABCG1-2 null mutant parasites
The relationships between ROS levels and autophagy in-
duction previously described in mammalian cells and
Leishmania [12, 34], prompted us to study whether
ΔLABCG1-2 parasites present a modification in ROS
levels during the parasite’s different growth cycle phases.
ROS levels in WT and add-back Leishmania lines
increased through the growth phases from early log
phase to mid log and early stationary phases, but subse-
quently diminished when the cells entered the stationary
phase (Fig. 6, time-points equivalent to 2, 4, 6 and 9 days,
respectively). However, in ΔLABCG1-2 parasites, ROS
levels were 2-fold higher than their control parasites
(WT) at the early stationary and stationary phases of
growth (Fig. 6); this phenotype was re-established to
WT levels in the add-back parasites (Fig. 6). Thus, the
period at which ROS levels were highest agrees with the
moment when autophagy was significantly reduced
(Fig. 5a). Similar findings have been reported in L. major
null mutant for ATG4.2 cysteine peptidase, which, al-
though it presents a significant increase in ROS levels at
different growth phases (mainly at the stationary phase),
was unable to form autophagosomes under starvation
conditions [12]. These results support previous findings
[12] suggesting that autophagy is important for the pro-
tection of parasites against ROS-mediated protein dam-
age and its absence results in elevated ROS levels.
An increase in thiols influences autophagy response in
ΔLABCG1-2 parasites
Redox imbalance has a key role in driving autophagy
[35]. In eukaryotic cells, a decrease in the GSH/GSSG
ratio due to a release of GSH to the extracellular milieu
mediated by ABCC1 and the concomitant increase of oxi-
dized thiols induces autophagy [14]. Evidence linking thiol
redox state with autophagy has been reported previously
[35]. The hypothesis does not exclude the possibility that
redox imbalance might regulate autophagy at multiple
levels. It has recently been demonstrated that nutrient
deprivation in carcinoma cells led to a significant decrease
Fig. 5 Autophagosome formation in promastigotes of L. major lines.
a The proportion of promastigotes from different lines including: control
(WT) (diamonds), ΔLABCG1-2 (squares), and ΔLABCG1-2 + LABCG1-2
(triangles) expressing RFP-ATG8 was assessed during the growth curve in
vitro. Data are the mean ± SD from three independent experiments. Stat-
istical differences relative to the WT values were determined using the
Student’s t test (*P< 0.05). b Western blot analysis of RFP-ATG8 in
different Leishmania lines. Promastigote cell extracts from different lines
(WT, ΔLABCG1-2 and ΔLABCG1-2 + LABCG1-2) transfected with RFP-
ATG8 were collected during the stationary growth phase, separated by
SDS-PAGE in the presence of 6 M urea and analysed by Western blot. A
Western blot assay representative of at least three independent
experiments is shown
Fig. 6 ROS levels along the growth cycle of Leishmania lines.
Promastigotes (1 × 107) were collected at early logarithmic (EL), mid
logarithmic (ML), early stationary (ES) and stationary (S) phases of
growth (2, 4, 6 and 10 days, respectively) and basal ROS levels were
measured by means of an H2DCFDA assay. Data are the mean ± SD
of three independent experiments. Significant differences versus the
respective control line were determined using Student’s t-test (*P< 0.05)
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of intracellular GSH levels and an activation of autophagy
[14]. In Leishmania parasites, the LABCG2 transporter
has been described as a non-protein thiol transporter [19].
In fact, we have found evidence that ΔLABCG1-2 para-
sites have modified intracellular thiols. No differences in
the parasite size that could explain the intracellular thiol
variance was observed between the different lines (data
not shown). As depicted in Fig. 7a, a significant increase
in thiol levels was observed in ΔLABCG1-2 parasites ver-
sus the control (WT) (t-test: t(4) = 47.90, P < 0.0001) and
add-back parasites (t-test: t(4) = 93.60, P < 0.0001); this in-
crease in thiols correlates with a low proportion of cells
containing autophagosomes (Fig. 7b), supporting the idea
that Leishmania LABCG1-2 transporters are involved in
autophagy and influence intracellular thiol levels. To as-
sess the specificity of these results we measured intracellu-
lar thiol levels in the presence of GSH synthesis inhibitor
BSO [36]. As shown in Fig. 7a, treatment with BSO
produces a decrease of GSH levels in WT and ΔLABCG1-
2 lines. However, we did not observe a significant decrease
in the add-back line, probably due to a slight overexpres-
sion of LABCG1-2 that could transport the CellTracker™
probe, which was previously shown to be transported by
human ABCG2 [37]. To evaluate whether the decrease in
thiols was associated with autophagosome generation, we
determined autophagosome formation in the presence or
absence of BSO. Figure 7b shows that BSO preincubation
for 48 h caused a decrease of intracellular GSH levels,
Fig. 7 Relationship between thiol levels and autophagosome formation
in L. major lines. a Parasites (WT, ΔLABCG1-2 and ΔLABCG1-2 + LABCG1-
2) transfected with pNUS RFP-ATG8 were pre-incubated for 48 h in M-
199 without (black histograms) or with (grey histograms) 3 mM BSO in
order to deplete thiol levels. After 8 days in culture, promastigotes (4 ×
106) were collected and incubated with 2 μM CellTracker™ for 15 min.
Fluorescence intensities were measured by flow cytometry. b In parallel,
we measured the proportion of promastigotes expressing RFP-ATG8
with (grey histograms) or without (black histograms) BSO treatment by
counting autophagosomes using a fluorescence microscope. Data are
the mean ± SD from three independent experiments. Significant
differences were determined by the Student’s t-test (*P < 0.01
versus WT; †P < 0.01 versus non-treated parasites)
Fig. 8 Reduced non-protein thiol levels in L. major lines. a Parasites
(3 × 108) were collected from different lines: WT (black histograms),
ΔLABCG1-2 (grey histograms), and ΔLABCG1-2 + LABCG1-2 (white
histograms) at stationary-phase growth. After three washes with PBS,
the cell pellet was resuspended in Tris-HCl 10 mM-EDTA supplemented
with 2% Triton X-100 and thiol levels quantified by flow cytometry. b
Promastigotes (1 × 109) from different lines were collected, lyophilised
and stored at 4 °C until used. The cell pellet was treated as described in
Materials and Methods. Data are the mean ± SD from three
independent experiments. Significant differences versus WT parasites
were determined with the Student’s t-test (*P < 0.01)
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while significantly increasing the percentage of cells con-
taining autophagosomes in all Leishmania lines (t-test: t(4)
= 8.38, P = 0.0011 for WT; t-test: t(4) = 20.82, P < 0.0001
for ΔLABCG1-2; t-test: t(4) = 11.03, P = 0.0004 for
ΔLABCG1-2 + LABCG1-2). These results provide evi-
dence that autophagosome formation in Leishmania is
directly linked to intracellular thiol levels and that a de-
crease in thiols stimulates the autophagy. Collectively, this
suggests that a decrease in thiols is a specific feature of
autophagy and that LABCG1-2 transporters are involved
in this process. The relationship between autophagy regu-
lation and GSH transport has been suggested previously
for human ABCG2 transporter [15].
We have quantified the levels of thiols in the different
Leishmania lines using DTNB probe, and the results show
that ΔLABCG1-2 parasites present significantly higher
levels of non-protein thiols (2.2-fold increase) versus those
observed in WT (t-test: t(4) = 17.30, P < 0.0001) and add-
back parasites (t-test: t(4) = 25.29, P < 0.0001) (Fig. 8a).
Additionally, we have determined by HPLC (Fig. 8b) that
GSH and T [SH] 2 were the main molecules that differen-
tially accumulated into ΔLABCG1-2 parasites, around 2-
fold for GSH and 1.5-fold for T [SH] 2 compared with
WT (t-test: t(6) = 3.91, P = 0.0078 for GSH; t-test: t(6) =
4.22, P = 0.0055 for T [SH] 2) and add-back parasites (t-
test: t(6) = 4.76, P = 0.0031 for GSH; t-test: t(6) = 10.72, P <
0.0001 for T [SH] 2) (Fig. 8b).
Future studies using membranes from baculovirus-
insect cell heterologous expression of LABCG1-2 will
confirm their involvement in non-protein thiols transport.
Conclusions
In conclusion, the Leishmania LABCG1-2 transporters
could be considered as GSH and T [SH] 2 thiol trans-
porters, as they can modulate the levels of these molecules
into the parasites influencing the autophagy process. Our
finding that LABCG1-2 expression is associated with
stress-induced autophagy indicates that these transporters
have a novel role beyond drug-resistance, PS transport and
virulence. LABCG1-2 transporters could interact with other
protein (s) and the consequently alteration of these interac-
tions may account for some of the observed phenotypes.
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